Recently, the factories and research and development centers of multinational companies in China, including many Fortune Global 500 companies, have also begun to resume work and production.

Workers are busy at a production base of L 'Oreal of France, a global Top 500 company, in Suzhou, Jiangsu province.

Zhang Qing, Production director of Suzhou Shangmei International Cosmetics Co., LTD. : 50% of the employees have returned to our factory and almost our production capacity has reached 50%. It is expected that by the end of February, all our employees will come back and our production capacity will reach the normal level.

In Pudong, Shanghai, Toyota Textiles, one of the world's top three manufacturers of car seats and interiors, has also resumed work.

Executive deputy General Manager of Toyota Textile (China) Co., LTD. Zhuang Zhiqiang: All employees in Shanghai are very positive and have come to work. We have more than 50 Japanese employees, most of whom are now in Shanghai, and we think we should shoulder this most difficult period with China.

Zhuhai, Guangdong Province, BP's largest chemical production base in China, continued production, including throughout the Spring Festival holiday.

Li Yong, general manager of Zhuhai Bibi Chemical Co., LTD. : Our enterprise is closely related to the national economy and people's livelihood, that is, with the people's clothes, food packaging and engineering plastics are closely related to some products, before and after the Spring Festival is to maintain a full load of production.

Not only the factories, but also the R & D centers of many multinational enterprises in China have resumed work.

China R & D and Innovation Center frontier research General manager Gao Yu: Our R & D center officially resumed work on February 10, in addition to the Yichang factory and Wuhan office, L 'Oreal China also resumed work on the same day according to the same time.

It is understood that the factories and R & D centers of multinational companies such as Schneider, BASF and General Electric in China are also gradually resuming work.

In the face of the epidemic, many multinational companies have expressed their support for the Chinese government's prevention and control measures. Many of them also said that the timely support policies introduced by the government have strengthened their confidence in the Chinese market.

In the process of actively responding to the epidemic, the Chinese government has issued timely and effective policies and measures to support the smooth operation of the real economy, BP said.

Li Yong, General Manager of Zhuhai Bibi Chemical Co., LTD. : We have received support policies from Zhuhai City and Guangdong Province to support enterprises to actively resume work and production, including tax and social security funds.

Gao Yu, general manager of Frontier research of L 'Oreal China R&D and Innovation Center: The government also has a lot of measures to help enterprises reduce the burden, to ensure that enterprises can operate normally and stably, so we feel very pleased and very confident.

Wang Lei, Executive Vice President of Astrazeneca Global and President of China: China's economy is very resilient, and the diligence and wisdom of the Chinese people will allow us to overcome the epidemic once again. As a foreign-funded enterprise, Astrazeneca will firmly continue to invest in China and maintain a more optimistic outlook.

A number of international securities management institutions believe that the current impact of the epidemic is only short-term, China's economy has strong resilience and great potential, and the long-term fundamentals have not changed. They continue to be optimistic about the prospects and opportunities of the development of China's economy and China's capital market. Many foreign employees of multinational companies have expressed their willingness to fight the epidemic together with their Chinese colleagues.

Plastic Industry Video